C. Visús

发表

Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8+ T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck.

R. Dhir, Dong-Myung Shin, T. Whiteside, 2007, Cancer research.

A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients

S. Steinberg, J. Berzofsky, M. Merino, 2012, Cancer Immunology, Immunotherapy.

Function but not phenotype of melanoma peptide‐specific CD8+ T cells correlate with survival in a multiepitope peptide vaccine trial (ECOG 1696)

J. Kirkwood, L. Butterfield, T. Whiteside, 2012, International journal of cancer.

Targeting ALDHbright Human Carcinoma–Initiating Cells with ALDH1A1-Specific CD8+ T Cells

R. Ferris, R. Brand, T. Whiteside, 2011, Clinical Cancer Research.

Identification of a 17β-hydroxysteroid dehydrogenase type 12 pseudogene as the source of a highly restricted BALB/c Meth A tumor rejection peptide

J. Shabanowitz, E. Appella, D. Hunt, 2009, Cancer Immunology, Immunotherapy.

Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables

C. Marosi, G. Ricken, J. Hainfellner, 2018, Acta Neuropathologica Communications.

17β Hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma.

T. Whiteside, A. Deleo, M. Zabel, 2012, Gynecologic oncology.

The Wild-Type Sequence (wt) p5325–35 Peptide Induces HLA-DR7 and HLA-DR11-Restricted CD4+ Th Cells Capable of Enhancing the Ex Vivo Expansion and Function of Anti-wt p53264–272 Peptide CD8+ T Cells1

E. Appella, T. Whiteside, D. Ito, 2006, The Journal of Immunology.

ExpansionCapable of Enhancing the Ex Vivo Th Cells + HLA-DR 11-Restricted CD 4 Peptide Induces HLA-DR 7 and 35 − 25 The Wild-Type Sequence ( wt ) p 53

E. Appella, T. Whiteside, D. Ito, 2006 .

Alterations in the T-Cell Receptor Variable β Gene–Restricted Profile of CD8+ T Lymphocytes in the Peripheral Circulation of Patients with Squamous Cell Carcinoma of the Head and Neck

R. Ferris, T. Whiteside, A. Albers, 2006, Clinical Cancer Research.

T Lymphocytes + Apoptosis in Tumor-Reactive Activated CD 8 Regulatory T Cell Expansion and Induce Tumor-Derived Microvesicles Promote

T. Whiteside, W. Storkus, E. Wieckowski, 2009 .

Inhibition of Poly(ADP-Ribose) Polymerase (PARP) Induces Apoptosis in Lung Cancer Cell Lines

J. Luketich, R. Landreneau, E. Meyer, 2011, Cancer investigation.

CSPG4 in cancer: multiple roles.

X. Wang, Y. Wang, C. Ferrone, 2010, Current molecular medicine.

Prognostic Significance and Diagnostic Value of Protein S-100 and Tyrosinase in Patients With Malignant Melanoma

A. Tres, M. Ruiz-Echarri, J. Mayordomo, 2008, American journal of clinical oncology.

Prognostic role of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction for tyrosinase mRNA in patients with melanoma

A. Tres, J. Mayordomo, J. Godino, 2007, Melanoma research.

Gliomasphere marker combinatorics: multidimensional flow cytometry detects CD44+/CD133+/ITGA6+/CD36+ signature

S. Spiegl-Kreinecker, D. Lötsch, W. Berger, 2018, Journal of cellular and molecular medicine.

Combined proteomics/miRNomics of dendritic cell immunotherapy-treated glioblastoma patients as a screening for survival-associated factors

B. Kuster, S. Spiegl-Kreinecker, D. Lötsch, 2020, npj Vaccines.

Spheroid glioblastoma culture conditions as antigen source for dendritic cell-based immunotherapy: spheroid proteins are survival-relevant targets but can impair immunogenic interferon γ production.

S. Spiegl-Kreinecker, D. Lötsch, W. Berger, 2019, Cytotherapy.

Tumor-Derived Microvesicles Promote Regulatory T Cell Expansion and Induce Apoptosis in Tumor-Reactive Activated CD8+ T Lymphocytes1

Carmen Visus, T. Whiteside, W. Storkus, 2009, The Journal of Immunology.

Phase I Dendritic Cell p53 Peptide Vaccine for Head and Neck Cancer

L. Butterfield, R. Ferris, A. Argiris, 2014, Clinical Cancer Research.

Identification of Hydroxysteroid (17β) dehydrogenase type 12 (HSD17B12) as a CD8+ T-cell-defined human tumor antigen of human carcinomas

Rajiv Dhir, Carmen Visus, R. Dhir, 2011, Cancer Immunology, Immunotherapy.

Immunological characterization of missense mutations occurring within cytotoxic T cell‐defined p53 epitopes in HLA‐A*0201+ squamous cell carcinomas of the head and neck

E. Appella, R. Ferris, T. Whiteside, 2007, International journal of cancer.

Cancer Therapy : Clinical Phase I Dendritic Cell p 53 Peptide Vaccine for Head and Neck Cancer

Eld, R. Ferris, A. Argiris, 2014 .

Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial

S. Spiegl-Kreinecker, J. Pichler, C. Marosi, 2018, Cancers.

Generation and immunosuppressive functions of p53-induced human adaptive regulatory T cells

T. Whiteside, S. Lang, O. Finn, 2013, Oncoimmunology.

A randomized phase II p53 vaccine trial comparing subcutaneous direct administration with intravenous peptide-pulsed dendritic cells in high risk ovarian cancer patients

S. Steinberg, J. Berzofsky, T. Whiteside, 2007 .

Results of a Pilot Trial of Immunotherapy with Dendritic Cells Pulsed with Autologous Tumor Lysates in Patients with Advanced Cancer

A. Güemes, A. Tres, J. Mayordomo, 2007, Tumori.

Automated, Miniaturized, and Integrated Quality Control-on-Chip (QC-on-a-Chip) for Cell-Based Cancer Therapy Applications

Mario Rothbauer, Peter Ertl, David Wartmann, 2015, Front. Mater..

Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables

C. Marosi, G. Ricken, J. Hainfellner, 2018, Acta neuropathologica communications.

Spontaneous apoptosis of tumor‐specific tetramer+ CD8+ T lymphocytes in the peripheral circulation of patients with head and neck cancer

T. Whiteside, A. Deleo, A. Albers, 2009, Head & neck.

Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8+ T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck.

R. Dhir, A. Deleo, V. Donnenberg, 2007, Cancer research.